Vaccine adjuvant discovery program (VADP)
Active Definitive Contract Awarded Last action
- Contract number
- 75N93024C00020
- Awardee
-
The Children's Hospital Corporation UEI Z1L9F1MM1RY3
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,547,484
Award facts
- Opportunity
-
- Vaccine adjuvant discovery program Pre-Solicitation · 75N93022R00022 · Posted Dec 5, 2022
- Contract value 34% obligated
-
- $2,547,484.00 Current, with exercised options
- $7,530,482.00 Potential, with all options
- Completion date 42% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 13 offers Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Place of performance
- Boston, MA 02115, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Change Order | $1,112,104 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $1,435,380 |
About this award
The National Institute of Allergy and Infectious Diseases awarded a $7.53 million definitive contract to The Children's Hospital Corporation, doing business as Boston Children's Hospital, for the Vaccine Adjuvant Discovery Program on September 30, 2024, under cost-no-fee pricing with no set-aside.
The program targets discovery of novel effective and safe vaccine adjuvants. Place of performance is Boston, MA. The contract runs through September 29, 2029. The originating solicitation was posted December 5, 2022, with a December 20, 2022 due date as a pre-solicitation notice.
Quick answers
Who was awarded contract 75N93024C00020?
75N93024C00020 was awarded to The Children's Hospital Corporation by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 30, 2024.
How much is contract 75N93024C00020 worth?
The government has obligated $2,547,484 on 75N93024C00020. Its potential value, with all options, is $7,530,482.
Was contract 75N93024C00020 competed?
The extent of competition for 75N93024C00020 was full and open competition. The government received 13 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award